Category - Ovarian Cancer

Thursday, September 27, 2012 - 5:29pm

Gynecologic Cancer Awareness Month (September) is the perfect time for women to make sure they understand their risk for ovarian cancer. The second most common type of gynecological cancer, ovarian cancer is also the most lethal because it is usually detected at later stages, when it is more difficult to treat.   

While we are still working to fully understand the underlying causes and risk factors for ovarian cancer, there are some red flags that you can use to understand if you may be at elevated risk. Take a minute to answer the questions below.

Thursday, February 23, 2012 - 12:26pm

An RPCI Cancer Talk reader inquired recently about the treatment and prognosis of borderline mucinous epithelial carcinoma. Because this is a diagnosis that may be unfamiliar to many, I would like to share my response here on Cancer Talk to help others understand what it is. Many thanks to the reader for submitting the question!

Tuesday, February 14, 2012 - 3:24pm

By studying the effects of bevacizumab (brand name AvastinTM), a drug currently FDA-approved for use in the treatment of several other cancers, a research team led by the Gynecologic Oncology Group (GOG)  has laid the groundwork for a possible new treatment option for women with advanced ovarian cancer—a treatment option that may increase the time women live without their disease worsening.